US cannabis legalization in the 2024 election? Will Joe Biden and the Democrats make cannabis reform a significant part of their re-election platform? With the potential...
“Tilray is too dangerous,” said CNBC’s “Mad Money” host Jim Cramer. “It is a spec stock that is losing money, and we don’t recommend stocks that...
What are the consequences of rescheduling cannabis in the United States? Last week, the federal Department of Health and Human Services (HHS) sent a memo to...
The U.S. Department of Health and Human Services (HHS) has recommended reclassifying cannabis to Schedule III, or a lower-risk drug. Currently, cannabis is considered Schedule I...
What is the future of the United States (U.S.) cannabis industry? While operators wait on the Biden administration to reschedule the herb and for Congress to...
What is Tilray’s potential in the global cannabis market? The company’s shares skyrocketed with their recent acquisition of eight beer and beverage brands from Anheuser-Busch InBev....
According to a new Gallup poll, 50% of Americans have tried cannabis. More people are smoking cannabis than cigarettes, with 17% (or one in six Americans)...
